Rapport Therapeutics, Inc (RAPP) insider trading

Every open-market stock purchase and sale by Rapport Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Steven M Paul (Insider) and 4 others bought $1.6M in the last 90 days, growing their stake 86%.
  • Abraham Ceesay (CEO) and 2 others sold $7M in the last 90 days.

Last 12 months: insiders bought $1.6M (5 buys) and sold $47.2M (33 sales). Last close $25.06 on Oct 21, 2026.

Recent RAPP insider trades

DateInsiderTradeValue
Oct 22, 2026Steven M Paul (Insider)Bought$974K
Oct 22, 2026John Maraganore (Insider)Bought$217K
Oct 22, 2026Wendy B. Young (Insider)Bought$100K
Oct 22, 2026Paul M Silva (Insider)Bought$99.6K
Oct 22, 2026John Maraganore (Insider)Bought$31.5K
Oct 21, 2026Troy A. Ignelzi (CFO)Bought$144K
Oct 7, 2026Abraham Ceesay (CEO)Sold$35.2K
Oct 6, 2026Abraham Ceesay (CEO)Sold$108K
Sep 30, 2026Cheryl Gault (COO)Sold$262K
Sep 30, 2026Cheryl Gault (COO)Sold$70K
Sep 23, 2026Abraham Ceesay (CEO)Sold$76.2K
Sep 23, 2026Abraham Ceesay (CEO)Sold$8.6K
Sep 23, 2026Abraham Ceesay (CEO)Sold$1.8K
Sep 8, 2026Abraham Ceesay (CEO)Sold$325K
Sep 8, 2026Abraham Ceesay (CEO)Sold$49.2K
Aug 25, 2026Krishnaswamy Yeleswaram (C-suite exec)Sold$1M
Aug 25, 2026Abraham Ceesay (CEO)Sold$938K
Aug 25, 2026Krishnaswamy Yeleswaram (C-suite exec)Sold$827K
Aug 24, 2026Krishnaswamy Yeleswaram (C-suite exec)Sold$658K
Aug 19, 2026Krishnaswamy Yeleswaram (C-suite exec)Sold$20.2K
Aug 11, 2026Abraham Ceesay (CEO)Sold$937K
Aug 11, 2026Abraham Ceesay (CEO)Sold$282K
Aug 11, 2026Abraham Ceesay (CEO)Sold$172K
Aug 10, 2026Abraham Ceesay (CEO)Sold$651K
Aug 10, 2026Abraham Ceesay (CEO)Sold$391K

Who's trading RAPP

Get free alerts when an insider at Rapport Therapeutics, Inc files a new trade →